In a Time of Universal Deceit, Telling the Truth is Revolutionary.
Thursday, September 29, 2022

Senate panel backs 12-year biotech drug shelter

WASHINGTON (Reuters) - Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.
Facebook
Twitter
LinkedIn

WASHINGTON (Reuters) – Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.

%d bloggers like this: